标题
The role of innate immune genes in Alzheimer's disease
作者
关键词
-
出版物
CURRENT OPINION IN NEUROLOGY
Volume 34, Issue 2, Pages 228-236
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2021-02-21
DOI
10.1097/wco.0000000000000911
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Siglecs as Immune Cell Checkpoints in Disease
- (2020) Shiteng Duan et al. Annual Review of Immunology
- Novel Alzheimer risk genes determine the microglia response to amyloid‐β but not to TAU pathology
- (2020) Annerieke Sierksma et al. EMBO Molecular Medicine
- The CD33 splice isoform lacking exon 2 as therapeutic target in human acute myeloid leukemia
- (2020) Colin D. Godwin et al. LEUKEMIA
- Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease
- (2020) Yingyue Zhou et al. NATURE MEDICINE
- TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge
- (2020) Alicia A. Nugent et al. NEURON
- Enhancing protective microglial activities with a dual function TREM 2 antibody to the stalk region
- (2020) Kai Schlepckow et al. EMBO Molecular Medicine
- A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease
- (2020) Harald Hampel et al. Frontiers in Immunology
- Microglial Corpse Clearance: Lessons From Macrophages
- (2020) Mar Márquez-Ropero et al. Frontiers in Immunology
- Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation
- (2020) Michael Ewers et al. EMBO Molecular Medicine
- Expanding use of CD33-directed immunotherapy
- (2020) Roland B. Walter EXPERT OPINION ON BIOLOGICAL THERAPY
- Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer’s disease model
- (2020) Shoutang Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Gene therapy for Alzheimer’s disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation
- (2020) Ana Griciuc et al. HUMAN MOLECULAR GENETICS
- Impact of TREM2R47H variant on tau pathology–induced gliosis and neurodegeneration
- (2020) Maud Gratuze et al. JOURNAL OF CLINICAL INVESTIGATION
- Genetic architecture of Alzheimer's disease
- (2020) Sarah M. Neuner et al. NEUROBIOLOGY OF DISEASE
- Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer’s Disease
- (2020) Joseph W. Lewcock et al. NEURON
- Single-Nucleus RNA-Seq Is Not Suitable for Detection of Microglial Activation Genes in Humans
- (2020) Nicola Thrupp et al. Cell Reports
- Microglial Phagocytosis: A Disease-Associated Process Emerging from Alzheimer’s Disease Genetics
- (2020) Anna Podleśny-Drabiniok et al. TRENDS IN NEUROSCIENCES
- Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
- (2019) Iris E. Jansen et al. NATURE GENETICS
- Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model
- (2019) Li Zhong et al. Nature Communications
- Alzheimer disease risk genes: 29 and counting
- (2019) Lars Bertram et al. Nature Reviews Neurology
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
- (2019) Brian W. Kunkle et al. NATURE GENETICS
- CCGG deletion (rs201074739) in CD33 results in premature termination codon and complete loss of CD33 expression: another key variant with potential impact on response to CD33-directed agents
- (2019) Ioannis Papageorgiou et al. LEUKEMIA & LYMPHOMA
- Microglia in Alzheimer's Disease: Exploring How Genetics and Phenotype Influence Risk
- (2019) Amanda McQuade et al. JOURNAL OF MOLECULAR BIOLOGY
- CD33 recruitment inhibits IgE-mediated anaphylaxis and desensitizes mast cells to allergen
- (2019) Shiteng Duan et al. JOURNAL OF CLINICAL INVESTIGATION
- Evaluation of CD33 as a genetic risk factor for Alzheimer’s disease
- (2019) Steven Estus et al. ACTA NEUROPATHOLOGICA
- Novel monoclonal antibody-based therapies for acute myeloid leukemia
- (2019) Linde M. Morsink et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Single-cell transcriptomic analysis of Alzheimer’s disease
- (2019) Hansruedi Mathys et al. NATURE
- The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques
- (2019) Carlo Sala Frigerio et al. Cell Reports
- TREM2 function impedes tau seeding in neuritic plaques
- (2019) Cheryl E. G. Leyns et al. NATURE NEUROSCIENCE
- TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer’s Disease
- (2019) Ana Griciuc et al. NEURON
- Controversies about the subcellular localization and mechanisms of action of the Alzheimer's disease-protective CD33 splice variant
- (2019) Sudeshna Saha et al. ACTA NEUROPATHOLOGICA
- Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer’s disease
- (2019) Michael Ewers et al. Science Translational Medicine
- Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism
- (2018) Wilbur M. Song et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2)
- (2018) Li Zhong et al. Molecular Neurodegeneration
- TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function
- (2018) Yingjun Zhao et al. NEURON
- Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models
- (2018) C.Y. Daniel Lee et al. NEURON
- Gemtuzumab ozogamicin for treatment of newly diagnosed CD33-positive acute myeloid leukemia
- (2018) Mohammed Gbadamosi et al. Future Oncology
- High‐affinity interactions and signal transduction between Aβ oligomers and TREM2
- (2018) Christian B Lessard et al. EMBO Molecular Medicine
- CD33 in Alzheimer’s Disease – Biology, Pathogenesis, and Therapeutics: A Mini-Review
- (2018) Lingzhi Zhao GERONTOLOGY
- Distinct cytokine profiles in human brains resilient to Alzheimer's pathology
- (2018) Isabel Barroeta-Espar et al. NEUROBIOLOGY OF DISEASE
- The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
- (2017) Susanne Krasemann et al. IMMUNITY
- The Alzheimer's disease–protective CD33 splice variant mediates adaptive loss of function via diversion to an intracellular pool
- (2017) Shoib S. Siddiqui et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Late onset Alzheimer’s disease genetics implicates microglial pathways in disease risk
- (2017) Anastasia G. Efthymiou et al. Molecular Neurodegeneration
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
- (2017) Rebecca Sims et al. NATURE GENETICS
- TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy
- (2017) Cheryl E. G. Leyns et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A human microglia-like cellular model for assessing the effects of neurodegenerative disease gene variants
- (2017) Katie J. Ryan et al. Science Translational Medicine
- TREM2, Microglia, and Neurodegenerative Diseases
- (2017) Felix L. Yeh et al. TRENDS IN MOLECULAR MEDICINE
- Evidence for C1q-mediated crosslinking of CD33/LAIR-1 inhibitory immunoreceptors and biological control of CD33/LAIR-1 expression
- (2017) Myoungsun Son et al. Scientific Reports
- Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status
- (2016) Laura Piccio et al. ACTA NEUROPATHOLOGICA
- sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
- (2016) Marc Suárez‐Calvet et al. EMBO Molecular Medicine
- TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
- (2016) Yaming Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease
- (2016) Taylor R. Jay et al. JOURNAL OF NEUROSCIENCE
- TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy
- (2016) Peng Yuan et al. NEURON
- TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia
- (2016) Felix L. Yeh et al. NEURON
- Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms
- (2016) Daniel L Kober et al. eLife
- TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
- (2015) Yaming Wang et al. CELL
- Genetics of CD33 in Alzheimer's disease and acute myeloid leukemia
- (2015) M. Malik et al. HUMAN MOLECULAR GENETICS
- Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
- (2015) Yuka Atagi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E
- (2015) Charles C. Bailey et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TREM2 deficiency eliminates TREM2+inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models
- (2015) Taylor R. Jay et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CD33 modulates TREM2: convergence of Alzheimer loci
- (2015) Gail Chan et al. NATURE NEUROSCIENCE
- Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex
- (2015) Douglas G. Walker et al. NEUROBIOLOGY OF AGING
- TREM2 and Risk of Alzheimer’s Disease — Friend or Foe?
- (2015) Rudolph E. Tanzi NEW ENGLAND JOURNAL OF MEDICINE
- CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimer's disease susceptibility
- (2014) T. Raj et al. HUMAN MOLECULAR GENETICS
- Negative Regulation of Toll-like Receptor-4 Signaling through the Binding of Glycosylphosphatidylinositol-anchored Glycoprotein, CD14, with the Sialic Acid-binding Lectin, CD33
- (2014) Akiko Ishida et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2
- (2014) Jason D Ulrich et al. Molecular Neurodegeneration
- Sensing the neuronal glycocalyx by glial sialic acid binding immunoglobulin-like lectins
- (2014) B. Linnartz-Gerlach et al. NEUROSCIENCE
- TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
- (2014) G. Kleinberger et al. Science Translational Medicine
- Disubstituted sialic acid ligands targeting siglecs CD33 and CD22 associated with myeloid leukaemias and B cell lymphomas
- (2014) Cory D. Rillahan et al. Chemical Science
- Dissecting phenotypic traits linked to human resilience to Alzheimer’s pathology
- (2013) Beatriz G. Perez-Nievas et al. BRAIN
- CD33 Alzheimer's Risk-Altering Polymorphism, CD33 Expression, and Exon 2 Splicing
- (2013) M. Malik et al. JOURNAL OF NEUROSCIENCE
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
- (2013) Jean-Charles Lambert et al. NATURE GENETICS
- CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology
- (2013) Elizabeth M Bradshaw et al. NATURE NEUROSCIENCE
- Identification of a unique TGF-β–dependent molecular and functional signature in microglia
- (2013) Oleg Butovsky et al. NATURE NEUROSCIENCE
- The microglial sensome revealed by direct RNA sequencing
- (2013) Suzanne E Hickman et al. NATURE NEUROSCIENCE
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
- (2013) Chia-Chen Liu et al. Nature Reviews Neurology
- Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
- (2013) Ana Griciuc et al. NEURON
- Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis
- (2013) Amanda Sierra et al. Frontiers in Cellular Neuroscience
- The Genetics of Alzheimer Disease
- (2013) R. E. Tanzi Cold Spring Harbor Perspectives in Medicine
- Variant of TREM2 Associated with the Risk of Alzheimer's Disease
- (2012) Thorlakur Jonsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- TREM2 Variants in Alzheimer's Disease
- (2012) Rita Guerreiro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of Novel Alzheimer’s Disease Risk Genes in Control and Alzheimer’s Disease Brains
- (2012) Celeste M. Karch et al. PLoS One
- Epitope mapping, expression and post-translational modifications of two isoforms of CD33 (CD33M and CD33m) on lymphoid and myeloid human cells
- (2011) A. B. Perez-Oliva et al. GLYCOBIOLOGY
- Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
- (2011) Adam C Naj et al. NATURE GENETICS
- Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
- (2011) Paul Hollingworth et al. NATURE GENETICS
- Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations
- (2011) Jean-Charles Lambert et al. NEUROBIOLOGY OF AGING
- Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease
- (2010) Sudha Seshadri JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
- (2009) Jean-Charles Lambert et al. NATURE GENETICS
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
- (2009) Denise Harold et al. NATURE GENETICS
- Genome-wide Association Analysis Reveals Putative Alzheimer's Disease Susceptibility Loci in Addition to APOE
- (2008) Lars Bertram et al. AMERICAN JOURNAL OF HUMAN GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started